Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Preclinical Preclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
PreclinicalPreclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Global trials
Image of people around a table for the Best Practices for Operationalizing Global, Early-Phase Oncology Trials webinar Webinar Best Practices for Operationalizing Global, Early-Phase Oncology Trials The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance Read Now World Map on Night Sky Universe Blog FDA Issues Draft Guidance on Conducting Multiregional Oncology Trials Clinical regulation helps enable consistent study results Oncology trials are becoming more global. While 22% Read Now